Levent Korkmaz

Levent Korkmaz

Auto-generated profile, based on publicly available information

Levent Korkmaz

Division of Neonatology, Department of Pediatrics, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Turkey

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2011 in Journal of Clinical Research in Pediatric Endocrinology
Verified
Journal Article
Open access
SKSelim Kurtoğlu
Selim Kurtoğlu
DSDilek Sarıcı
Dilek Sarıcı
MAMustafa Ali Akın
Mustafa Ali Akın
GDGhaniya Daar
Ghaniya Daar
LKLevent Korkmaz
Levent Korkmaz
ŞMŞeyma Memur
Şeyma Memur
During pregnancy, steroids are usually used in maternal diseases such as adrenal failure or other autoimmune diseases, e.g. idiopathic thrombocytopenic purpura (ITP), Crohn's disease, systemic lupus erythematosus, dermatomyositis, scleroderma, Addison's disease and hyperemesis gravidarum, HELLP syndrome. Endogenous or exogenousmaternal steroids are metabolized by the placental enzyme 11 beta-hydroxy steroid dehydrogenase type 2. Prednisolone and methylprednisolone are highly sensitive to this enzyme, while dexamethasone and betamethasone are less well metabolized. Steroids which can cross the placental barrier are administered in cases like fetal lupus, congenital adrenal hyperplasia and for enhancement of fetal lung maturation, whereas steroids used in maternal diseases are usually the ones with low affinity to the placenta; however, in case of long-term use or in high doses, placental enzyme saturation occurs and thus, resulting in fetal adrenal suppression. Antenatal steroids can lead to low birth weight, as observed in our patient. Here, we report a case with fetal adrenal suppression due to maternal methylprednisolone use presenting with early hypoglycaemia and late hyponatremia in neonatal period and requiring three-month replacement therapy.

1 October 2018 in Pediatrics & Neonatology
Verified
Journal Article
Open access
LKLevent Korkmaz
Levent Korkmaz
OBOsman Baştuğ
Osman Baştuğ
AÖAhmet Özdemir
Ahmet Özdemir
SKSabriye Korkut
Sabriye Korkut
ÇKÇağatay Karaca
Çağatay Karaca
MÖMehmet Adnan Öztürk
Mehmet Adnan Öztürk
Retinopathy of prematurity (ROP) is a proliferative vitreoretinopathy resulting from vascular defect of the retina. The present study evaluates platelets, which are involved in VEGF storage, transport and release, and their functions with regard to the prognosis of the disease. The objective was to suggest a simple minimal invasive method that will facilitate the management of the disease and help clinicians in predicting the prognosis. In this single center, retrospective, case-control study, we included a control group consisting of very preterm newborns (n = 83) at risk of ROP and a laser photocoagulation group including infants (n = 63) who received laser therapy during their follow-up examinations. The employed assessments included platelet counts and platelet mass index (PMI) which provide guidance in understanding platelet activity. In doing so, consideration was given to the first and second phases of ROP. The accuracy of prognostication was assessed with receiver operating characteristic analyses. The study groups did not differ statistically significantly by platelet count during the first and second phases of ROP (p > 0.05) nor were the PMI measurements statistically significantly different between the study groups during the first phase of the disease (p > 0.05). PMI values of the study groups, however, differed significantly in the second phase of ROP (p < 0.05). The present study found a significant difference between the two groups in PMI measurements which reflect increased VEGF levels during the neovascularization phase, which underlies the disease. This conclusion demonstrated that monitoring the PMI values in newborns at risk of ROP can be considered to be a minimally invasive method that by changing the retinal examination procedure in use today which is rather troublesome for both the physician and the newborn, can provide facilities in monitoring the disease for both the physician and the newborn.

1 June 2016 in Journal of Clinical Research in Pediatric Endocrinology
Verified
Journal Article
Open access
LKLevent Korkmaz
Levent Korkmaz
OBOsman Baştuğ
Osman Baştuğ
SKSelim Kurtoğlu
Selim Kurtoğlu
Obesity, in childhood or in adulthood, remains to be a global health problem. The worldwide prevalence of obesity has increased in the last few decades, and consequently, the women of our time suffer more gestational problems than women in the past. The prevalence of obesity is greater in older women than in younger ones and in women with low educational level than in their counterparts with a higher level of education. Maternal obesity during pregnancy may increase congenital malformations and neonatal morbidity and mortality. Maternal obesity is associated with a decreased intention to breastfeed, decreased initiation of breastfeeding, and decreased duration of breastfeeding. We discuss the current epidemiological evidence for the association of maternal obesity with congenital structural neural tube and cardiac defects, fetal macrosomia that predisposes infants to birth injuries and to problems with physiological and metabolic transition, as well as potential for long-term complications secondary to prenatal and neonatal programming effects compounded by a reduction in sustained breastfeeding.

18 September 2018 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
MOMehmet Adnan Ozturk
Mehmet Adnan Ozturk
LKLevent Korkmaz
Levent Korkmaz

19 December 2018 in American Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
LKLevent Korkmaz
Levent Korkmaz
OBOsman Bastug
Osman Bastug
AOAhmet Ozdemir
Ahmet Ozdemir
MCMahir Ceylan
Mahir Ceylan
TGTamer Gunes
Tamer Gunes
SKSabriye Korkut
Sabriye Korkut
Objective Intraventricular hemorrhage (IVH) is an important problem in neonatal units not only in terms of its consequences but also its follow-up and the prediction of its emergence in newborns. In this study, we have compared platelet parameters such as platelet count (PC), mean platelet volume (MPV), and platelet mass index (PMI) in terms of IHV in very-low-birth-weight (VLBW) newborns. Thus, we have tried to determine platelet values to guide clinicians in both the prediction and follow-up of IVH. Study Design This is a retrospective, multicenter, and case-controlled study. In this study, 386 cases of VLBW newborns (below 1,500 g) and gestational age below 32 weeks, hospitalized and monitored between August 8, 2012, and April 7, 2018, were included. The platelet values of the cases on their 12th hour postpartum (PC1, MPV1, and PMI1) and the platelet values on days 5 to 7 (PC2, MPV2, and PMI2) were recorded in their study cards. A p-value of <0.05 was accepted as statistically significant. Results While there was no difference of PC1, MPV1, PMI1, PC2, or MPV2 values (p > 0.05), PMI2 values in the severe stage IVH group cases were found to be significantly lower compared with other platelet parameters (p < 0.05). Conclusion PMI2 values can provide clinicians with important knowledge that may aid them in recognizing important pathologies such as IVH.

14 February 2017 in World Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
OBOsman Bastug
Osman Bastug
LKLevent Korkmaz
Levent Korkmaz
HHHulya Halis
Hulya Halis
SMSeyma Memur
Seyma Memur
SKSabriye Korkut
Sabriye Korkut
SKSelim Kurtoglu
Selim Kurtoglu